In HNSCC patients, EGFR-reactive T cell frequencies correlate with EGFR expression in cancer without any clinical features of autoimmunity suggesting that these T cells can recognize tumor as an antigen but not normal tissue in which the amount of EGFR epitope might not be enough to exceed the threshold of TCR signaling24. This evidence concerns the gene EGFR and cancer.